Monday, September 21, 2026

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

North Korea’s Upcoming Elections: What to Expect from the 15th Supreme People’s Assembly Candidates

North Korea is preparing for the 15th Supreme People's Assembly elections with excitement, though critics view the process as largely symbolic.

Hand, Foot and Mouth Disease Cases Surge Among Young Children as Summer Outbreak Season Begins

Hand, foot and mouth disease is resurging among young children, with increased cases reported in daycare centers. Parents are concerned.

Jin Joong Hwang

Author's Latest

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Unlock Better Sleep: Daewon Health’s New Honey Sleep Shot Hits Olive Young!

Daewon Pharmaceutical launches Good Night Shot, a sleep aid featuring lime peel extract, at Olive Young's seasonal sale for millennials and Gen Z.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

Celltrion’s Strategic Move: How Local Production in the U.S. Can Mitigate Tariff Risks

Celltrion outlines its Branchburg facility's operations and plans to mitigate tariff risks by establishing local production and a supply system.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Discover the Future of Aesthetic Treatments: How Nanotechnology is Transforming the Beauty Industry

DongKoo Bio&Pharma partners with Supernova Bio and Areum Medics to innovate aesthetic treatments using advanced nanoparticle technology.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

K-Spine Surgery: How a Korean Firm Showcased Minimally Invasive Techniques at U.S. Conference

CGBIO successfully held a symposium on minimally invasive spinal surgery, enhancing skills of over 100 global professionals through hands-on training.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Discover the Future of Aesthetic Medicine: URO-UEMXD and Derma Shine Duo RF Unveiled at WHX Dubai 2026

Huons Meditech showcased innovative medical devices at WHX Dubai 2026, highlighting advancements in urology and aesthetics.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Korean Spine-Implant Maker Targets Japan: L&K Biomed Showcases BluEX-LT at the Scoliosis Research Society Meeting

L&K Biomed showcased its products at the SRS conference in Japan, aiming to expand its market share in the APAC region, especially Japan.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.